Top Markets
#1 Nesa Nesa +337.52%
#2 EXOD EXOD +22.78%
#3 MetaDAO MetaDAO +14.79%
#4 Status Status +14.51%
#5 Wrapped NXM Wrapped NXM +7.60%
#6 PondCoin PondCoin +7.41%
#7 Kinesis Silver Kinesis Silver +6.73%
#8 Venom Venom +6.55%
#9 Wrapped Aave Ethereum WETH Wrapped Aave Ethereum WETH +6.48%
#10 Ontology Gas Ontology Gas +5.41%
Coin of the day
Nesa Nesa
Einstellungen
Sprache
DEUTSCH
Währung
USD
Thema
UnicoCell Biomed Co., Ltd. UnicoCell Biomed Co., Ltd.

UnicoCell Biomed Co., Ltd.

6794
Rang in Aktien #19718
UnicoCell Biomed Co., Ltd., a Taiwanese enterprise, specializes in the... UnicoCell Biomed Co., Ltd., a Taiwanese enterprise, specializes in the research, development, and application of stem cell-based pharmaceuticals, advanced cell therapy techniques, and regenerative medical solutions. Their flagship product, ELIXCYTE, is presently undergoing Phase 2 clinical trials, targeting both osteoarthritis and chronic kidney disease. Beyond therapeutics, the company also offers UnicoVial, a specialized cryopreservation and drug containment system designed for cell therapy products, and provides a range of related testing services.
Aktienkurs
$2.40
Zuletzt synchronisiert: 2026-08-25
Marktkapitalisierung
$152.78M
Veränderung (1 Tag)
0.67%
Veränderung (1 Jahr)
-4.09%
Land
TW
Handel UnicoCell Biomed Co., Ltd. (6794)

Kategorie

Healthcare
Kursverlauf für UnicoCell Biomed Co., Ltd. (6794)
Höchster Schlusskurs: $2.30 am 2026-08-01

Niedrigster Schlusskurs: $2.58 am 2024-05-01
Kursverlauf der Aktie von UnicoCell Biomed Co., Ltd. von 2024 bis 2026
Jährliche Kursentwicklung
Jahr Leistung
2026 (TTM) -2.17%
2025 20.54%
2024 0.00%
Aktienkurs vergleichbarer Unternehmen oder Wettbewerber
Unternehmen Aktienkurs Veränderung 1J% Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $553.09 42.85%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $1.02K 44.02%
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $158.64 541.49%
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $123.07 -11.95%
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $772.27 7.33%
CH